Article Versions Notes

Campolo M, Scuderi SA, Filippone A, Bova V, Lombardo SP, Colarossi L, Sava S, Capra AP, De Gaetano F, Portelli M, et al. EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation. Pharmaceuticals. 2024; 17(8):1102. https://doi.org/10.3390/ph17081102

Campolo, Michela, Sarah Adriana Scuderi, Alessia Filippone, Valentina Bova, Sofia Paola Lombardo, Lorenzo Colarossi, Serena Sava, Anna Paola Capra, Federica De Gaetano, Marco Portelli, and et al. 2024. "EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation" Pharmaceuticals 17, no. 8: 1102. https://doi.org/10.3390/ph17081102

Campolo, M., Scuderi, S. A., Filippone, A., Bova, V., Lombardo, S. P., Colarossi, L., Sava, S., Capra, A. P., De Gaetano, F., Portelli, M., Militi, A., Esposito, E., & Paterniti, I. (2024). EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation. Pharmaceuticals, 17(8), 1102. https://doi.org/10.3390/ph17081102